{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:31:07Z","timestamp":1684470667102},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T00:00:00Z","timestamp":1279756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1038\/hr.2010.129","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T06:04:03Z","timestamp":1279778643000},"page":"883-885","source":"Crossref","is-referenced-by-count":1,"title":["Combined rho kinase and renin\u2013angiotensin system inhibition: a new therapeutic perspective for renal and cardiovascular remodeling"],"prefix":"10.1038","volume":"33","author":[{"given":"Jorge E","family":"Jalil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Jalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Paz","family":"Ocaranza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,22]]},"reference":[{"key":"BFhr2010129_CR1","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1157\/13078132","volume":"58","author":"JE Jalil","year":"2005","unstructured":"Jalil JE, Lavandero S, Chiong M, Ocaranza MP . Rho\/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling. Rev Esp Cardiol 2005; 58: 951\u2013961.","journal-title":"Rev Esp Cardiol"},{"key":"BFhr2010129_CR2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1161\/HYPERTENSIONAHA.107.095117","volume":"50","author":"P Rivera","year":"2007","unstructured":"Rivera P, Ocaranza MP, Lavandero S, Jalil JE . RHO kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin-I-converting enzyme levels. Hypertension 2007; 50: 792\u2013798.","journal-title":"Hypertension"},{"key":"BFhr2010129_CR3","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/01.HYP.0000221605.94532.71","volume":"47","author":"Y Ishikawa","year":"2006","unstructured":"Ishikawa Y, Nishikimi T, Akimoto K, Ishimura K, Ono H, Matsuoka H . Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats. Hypertension 2006; 47: 1075\u20131083.","journal-title":"Hypertension"},{"key":"BFhr2010129_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/HJH.0b013e3280825440","volume":"25","author":"T Nishikimi","year":"2007","unstructured":"Nishikimi T, Koshikawa S, Ishikawa Y, Akimoto K, Inaba C, Ishimura K, Ono H, Matsuoka H . Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats. J Hypertens 2007; 25: 1053\u20131063.","journal-title":"J Hypertens"},{"key":"BFhr2010129_CR5","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1097\/HJH.0b013e328305086c","volume":"26","author":"S Koshikawa","year":"2008","unstructured":"Koshikawa S, Nishikimi T, Inaba C, Akimoto K, Matsuoka H . Fasudil a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats. J Hypertens 2008; 26: 1837\u20131848.","journal-title":"J Hypertens"},{"key":"BFhr2010129_CR6","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1681\/ASN.2005121375","volume":"17","author":"GP Sun","year":"2006","unstructured":"Sun GP, Kohno M, Guo P, Nagai Y, Miyata K, Fan YY, Kimura S, Kiyomoto H, Ohmori K, Li DT, Abe Y, Nishiyama A . Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury. J Am Soc Nephrol 2006; 17: 2193\u20132201.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr2010129_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.biopha.2009.06.001","volume":"64","author":"G Wu","year":"2010","unstructured":"Wu G, Tu Y, Jia R . The influence of fasudil on the epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells from diabetic rats. Biomed Pharmacother 2010; 64: 124\u2013129.","journal-title":"Biomed Pharmacother"},{"key":"BFhr2010129_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/FJC.0b013e31816533b7","volume":"51","author":"S Fukui","year":"2008","unstructured":"Fukui S, Fukumoto Y, Suzuki J, Saji K, Nawata J, Tawara S, Shinozaki T, Kagaya Y, Shimokawa H . Long-term inhibition of Rho-kinase ameliorates diastolic heart failure in hypertensive rats. J Cardiovasc Pharmacol 2008; 51: 317\u2013326.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr2010129_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.regpep.2009.12.002","volume":"160","author":"S Kagiyama","year":"2010","unstructured":"Kagiyama S, Matsumura K, Goto K, Otsubo T, Iida M . Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice. Regul Pept 2010; 160: 133\u2013139.","journal-title":"Regul Pept"},{"key":"BFhr2010129_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/cvr\/cvp135","volume":"83","author":"SB Haudek","year":"2009","unstructured":"Haudek SB, Gupta D, Dewald O, Schwartz RJ, Wei L, Trial J, Entman ML . Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardiovasc Res 2009; 83: 511\u2013518.","journal-title":"Cardiovasc Res"},{"key":"BFhr2010129_CR11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/hr.2010.112","volume":"33","author":"Y Takeda","year":"2010","unstructured":"Takeda Y, Nishikimi T, Akimoto K, Matsuoka H, Ishimitsu T . Beneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstruction.Hypertens Res 2010; 33: 965\u2013973.","journal-title":"Hypertens Res"},{"key":"BFhr2010129_CR12","doi-asserted-by":"publisher","first-page":"F861","DOI":"10.1152\/ajprenal.00362.2001","volume":"283","author":"S Klahr","year":"2002","unstructured":"Klahr S, Morrissey J . Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002; 283: F861\u2013F875.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFhr2010129_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1476-9255-7-19","volume":"7","author":"MT Grande","year":"2010","unstructured":"Grande MT, P\u00e9rez-Barriocanal F, L\u00f3pez-Novoa JM . Role of inflammation in t\u00fabulo-interstitial damage associated to obstructive nephropathy. J Inflammation 2010; 7: 19.","journal-title":"J Inflammation"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2010129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010129","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:05:35Z","timestamp":1684429535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2010129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,22]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["BFhr2010129"],"URL":"https:\/\/doi.org\/10.1038\/hr.2010.129","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,22]]}}}